SUPERNUS PHARMACEUTICALS, INC. ($SUPN)
Filing Information
| Accession Number | 0001899935-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 23, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
13,425
Total Value
$228,264.93
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 19, 2026 | Exercise/Conversion | 4,475 | $0.00 | $0.00 | 4,475 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 19, 2026 | Sale | 1,217 | $50.31 | $61,227.27 | 3,258 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 19, 2026 | Sale | 3,258 | $51.27 | $167,037.66 | 0 | Direct | โ | View Details | |
Director | Restricted Stock Unit | Derivative | Feb 19, 2026 | Exercise/Conversion | 4,475 | $0.00 | $0.00 | 0 | Direct | โ | View Details |